SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950123-05-014972
Filing Date
2005-12-20
Accepted
2005-12-20 10:56:52
Documents
2
Group Members
ALEXANDRA INVESTMENT MANAGEMENT LLCDIMITRI SOGOLOFFMIKHAIL A FILIMONOV

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G y15827sc13g.txt SC 13G 19295
2 JOINT FILING AGREEMENT y15827exv99wi.txt EX-99.I 2017
  Complete submission text file 0000950123-05-014972.txt   23308
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 051274459
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ALEXANDRA INVESTMENT MANAGEMENT LLC 767 THIRD AVE 39TH FLOOR NEW YORK NY 10017 2123011800
ALEXANDRA GLOBAL MASTER FUND LTD (Filed by) CIK: 0001266087 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G